WebCompany Type For Profit. Contact Email [email protected]. Phone Number 0755-36352085. Genoimmune Therapeutics is a holding subsidiary of Shenzhen Huada … Genoimmune Therapeutics has raised a total of CN¥120M in funding over 1 … Genoimmune Therapeutics has 2 current employee profiles, including Founder & … Technology - Genoimmune Therapeutics - Crunchbase Company Profile & Funding Edit Recent News & Activity Section. Funding Round • Mar 20, 2024 • Mar 20, … Genoimmune Therapeutics is a high-tech biotechnology enterprise dedicated to … WebGenoimmune Therapeutics Co Ltd Original Assignee Genoimmune Therapeutics Co Ltd Priority date (The priority date is an assumption and is not a legal conclusion. Google …
Genoimmune Therapeutics VentureRadar
WebGenoImmune Therapeutics, a subsidiary of BGI Genomics, is committed to tumor immune cell therapy through high-tech biotechnology. It develops a service package to detect … Web1. 1.-20. (canceled) 21. An isolated polypeptide, selected from the group consisting of: (1) a polypeptide having the amino acid sequence of SEQ ID NO:1; (2) a polypeptide … fairway remote login
XIAMEN INNODX BIOTECHNOLOGY CO., LTD.
WebJan 4, 2024 · Filed by Genoimmune Therapeutics Co., Ltd., Hubei (CN) Prior Publication US 2024/0263864 A1, Aug. 29, 2024: Int. Cl. C12Q 1/68 (2024.01); G01N 33/574 … WebThe 18th Annual Meeting of the International Conference on Genomics (ICG-18) commenced on April 12, 2024, in Zhangjiajie. This event marks the 25th anniversary… WebSep 30, 2016 · Date of Patent: January 4, 2024 Assignee: Genoimmune Therapeutics Co., Ltd. Inventors: Shuntao Luo, Bo Li, Yong Hou, Xiumei Lin, Ting An Tumor-specific polypeptide and use thereof Patent number: 11161874 Abstract: The present invention relates to a novel tumor-specific polypeptide and use thereof. do inofia mattresses have fiberglass